| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $42.2M | — | -34.0% |
| Cost of Revenue | $30.9M | — | -23.8% |
| Gross Profit | $11.3M | — | -51.7% |
| R&D Expense | $4.6M | — | +14.6% |
| SG&A Expense | $8.5M | — | +3.7% |
| Operating Income | -$14.1M | — | -1015.4% |
| Interest Expense | $1.4M | — | -30.0% |
| Pre-tax Income | -$15.3M | — | -1883.1% |
| Income Tax | -$123K | — | -12.8% |
| Net Income | -$15.2M | — | -2190.1% |
| EPS (Basic) | -$0.78 | — | -2500.0% |
| EPS (Diluted) | -$0.78 | — | -2500.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.3M | -27.4% | +5.4% |
| Accounts Receivable | $30.4M | -60.4% | -28.2% |
| Inventory | $64.3M | -7.1% | -12.7% |
| Current Assets | $117.7M | -32.3% | -17.2% |
| Total Assets | $209.9M | -22.0% | -15.0% |
| Current Liabilities | $47.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $29.4M | — | -27.4% |
| Capital Expenditures | $276K | — | +66.3% |
| Investing Cash Flow | -$276K | — | -111.7% |
| Financing Cash Flow | -$33.7M | — | +24.9% |
| Free Cash Flow | $29.1M | — | -27.8% |
| -34.0% |
| Long-term Debt | $53.6M | -3.8% | +10.1% |
| Total Liabilities | $98.1M | -30.2% | -22.3% |
| Stockholders' Equity | $111.9M | -12.9% | -7.5% |